Journal of Emergencies, Trauma, and Shock
Home About us Editors Ahead of Print Current Issue Archives Search Instructions Subscribe Advertise Login 
Users online:162   Print this pageEmail this pageSmall font sizeDefault font sizeIncrease font size   


 
 Table of Contents    
EXPERT COMMENTARY  
Year : 2018  |  Volume : 11  |  Issue : 1  |  Page : 2-3
Early Predictive Factors of Hypofibrinogenemia in Acute Trauma Patients


Professor, Department of Surgery, Puducherry Institute of Medical Sciences, Puducherry, India

Click here for correspondence address and email

Date of Submission29-Jul-2017
Date of Acceptance01-Aug-2017
Date of Web Publication19-Feb-2018
 

How to cite this article:
Radjou AN. Early Predictive Factors of Hypofibrinogenemia in Acute Trauma Patients. J Emerg Trauma Shock 2018;11:2-3

How to cite this URL:
Radjou AN. Early Predictive Factors of Hypofibrinogenemia in Acute Trauma Patients. J Emerg Trauma Shock [serial online] 2018 [cited 2018 Oct 17];11:2-3. Available from: http://www.onlinejets.org/text.asp?2018/11/1/2/225768




It is a well-known fact that the seriously injured have a six times higher risk of fatality in developing countries due to the lack of mature trauma systems. Nearly, 25%–40% of early trauma deaths is due to bleeding which is potentially preventable and hence can be targeted to reduce mortality. Necessary infrastructure for prompt surgical control is of prime importance, and most of the major hospitals in developing countries do have the expertise. However, trauma-induced coagulopathy (TIC) is a well-recognized entity and leads to bad outcomes in spite of prompt surgical control.[1]

TIC results from a combination of bleeding-induced shock, tissue injury-related thrombin-thrombomodulin-complex generation, and the activation of anticoagulant and fibrinolytic pathways.[2]

Hypofibrinogenemia and increased fibrinogen breakdown are key elements of TIC.[1] Hence, immediate correction of the acquired coagulation disorder should be the primary goal of the treatment protocols for bleeding.[2] TIC has already set in by the time patient reaches the hospital, more so in immature trauma systems, which the authors have rightly highlighted.

TIC is multifactorial no doubt but fibrinogen is the first coagulation factor to reach a critically low concentration during activation of coagulation in bleeding, and its reduction is associated with a worse outcome in injured patients.[3]

Thus, an attempt at early detection of derangements with available resources is prudent. Among the various hemostatic treatments available, supplementation of fibrinogen has received growing attention in the last decade.[4]

Fibrinogen can be given as fresh frozen plasma (FFP), cryoprecipitate, or fibrin concentrate. Each of these components has specific limits to the level and timing that fibrin can be replenished. The role of fibrinogen concentrate in trauma-induced coagulopathy has been the object of intense research in the past 10 years.

Developing countries do have stand alone trauma centers with state of the art blood bank services and point of care assessment to detect the specific deranged component in TIC. However, most of the seriously injured are cared for in high volume general hospitals where resource allocation will depend on the priorities essential for that particular health-care system. Resource allocation in trauma itself may be fragmented. Fibrin is available in their facility, but point of care measurements of coagulopathy like Rotem is not available. The authors have attempted to pin point clinical parameters to predict hypofibrinogenemia. A prospective study by Meyer et al. involving 182 seriously injured patients to a level 1 trauma center, sought to delineate the level of fibrinogen by Clauss method as that ascertained by the gold standard of thromboelastography. The viscoelastic hemostatic assays for determining fibrinogen levels correlated with the Clauss fibrinogen level, and there are no differences in the strength of these correlations.[5]

Indeed, although a number of randomized controlled trials investigating the use of fibrinogen concentrate in severe traumatic hemorrhage are currently underway, their results have not yet been published in full.[2]

Recently, published trauma guidelines suggest that fibrinogen supplementation should occur in the presence of plasma fibrinogen levels <1.5–2 g/L or thromboelastometric signs of fibrinogen deficiency.[6] The results of a meta-analysis do not support a benefit in terms of survival from the use of fibrinogen concentrate in the setting of severe trauma.[7] However, the ideal massive transfusion protocol in trauma remains elusive, with considerable geographical and institutional variation.[8] The authors have attempted to find out what could work best for them in their set up. This first step, in the right direction would augur well if they can take this forward, by a prospectively designed study where hypothermia (an easily available clinical parameter) is also factored in.



 
   References Top

1.
Floccard B, Rugeri L, Faure A, Saint Denis M, Boyle EM, Peguet O, et al. Early coagulopathy in trauma patients: an on-scene and hospital admission study. Injury 2012;43:26-32.  Back to cited text no. 1
[PUBMED]    
2.
Maegele M, Schöchl H, Cohen MJ. An update on the coagulopathy of trauma. TIC results from a combination of bleeding-induced shock, tissue injury-related thrombin-thrombomodulin-complex generation and the activation of anticoagulant and fibrinolytic pathways. Shock 2014;41:21-5.  Back to cited text no. 2
    
3.
Hiippala ST, Myllylä GJ, Vahtera EM. Hemostatic factors and replacement of major blood loss with plasma-poor red cell concentrates. Anesth Analg 1995;81:360-5.  Back to cited text no. 3
    
4.
Franchini M, Lippi G. Fibrinogen replacement therapy: A critical review of the literature. Blood Transfus 2012;10:23-7.  Back to cited text no. 4
    
5.
Meyer MA, Ostrowski SR, Sørensen AM, Meyer AS, Holcomb JB, Wade CE, et al. Fibrinogen in trauma, an evaluation of thrombelastography and rotational thromboelastometry fibrinogen assays. J Surg Res 2015;194:581-90  Back to cited text no. 5
    
6.
Rossaint R, Bouillon B, Cerny V, Coats TJ, Duranteau J, Fernández-Mondéjar E, et al. The European guideline on management of major bleeding and coagulopathy following trauma: Fourth edition. Crit Care 2016;20:100.  Back to cited text no. 6
    
7.
Mengoli C, Franchini M, Marano G, Pupella S, Vaglio S, Marietta M, et al. The use of fibrinogen concentrate for the management of trauma-related bleeding: A systematic review and meta-analysis. Blood Transfus 2017;15:318-24.  Back to cited text no. 7
    
8.
Dutton RP. Management of traumatic haemorrhage – The US perspective. Anaesthesia 2015;70 Suppl 1:108-11, e38.  Back to cited text no. 8
    

Top
Correspondence Address:
Prof. Angeline Neetha Radjou
Professor, Department of Surgery, Puducherry Institute of Medical Sciences, Puducherry
India
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/JETS.JETS_83_17

Rights and Permissions




 

Top
  
 
  Search
 
  
    Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
    Email Alert *
    Add to My List *
* Registration required (free)  


    References

 Article Access Statistics
    Viewed570    
    Printed38    
    Emailed0    
    PDF Downloaded9    
    Comments [Add]    

Recommend this journal